Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 40 clinical trials
DOTATATE PETMRI AAA Study

. This study will develop an imaging tool PETMRI with radiotracer Ga- DOTATATE with high clinical utility, to improve prediction of aneurysm growth and risk.

  • 0 views
  • 31 Mar, 2021
  • 1 location
68Ga-DOTATATE Neuroblastoma Imaging Pilot

and safety of 68Ga-DOTATATE and to compare it to 123I-MIBG when investigating neuroblastoma.

68ga-dotatoc
  • 0 views
  • 12 May, 2022
  • 1 location
Direct Comparison of Ga-68-DOTATATE and Ga-68-DOTATOC

The goal of this study is to propose the first direct comparison of Ga-68-DOTATATE PET and Ga-68-DOTATOC PET in patients with meningioma.

somatostatin
dotatate
dotatoc
  • 3 views
  • 19 Apr, 2022
  • 1 location
Lu-177-DOTATATE (Lutathera) in Therapy of Inoperable Pheochromocytoma/ Paraganglioma

safety and tolerability of Lu-177-DOTATATE. Also, to see if it improves the length of time it takes for the cancer to return. Eligibility Adults who have an

radionuclide therapy
adrenaline
hysterectomy
fdg pet/ct
18f-fdg
  • 6 views
  • 16 May, 2022
  • 1 location
Gallium Ga 68-DOTATATE PET/CT in Predicting Tumor Growth in Patients With Meningiomas

This phase I trial studies how well gallium Ga 68-DOTATATE positron emission tomography (PET)/computed tomography (CT) works in predicting tumor growth in patients with meningiomas. Giving

residual tumor
ct scan
dotatate
positron emission tomography
  • 26 views
  • 08 Feb, 2022
  • 1 location
Phase II Study of 177Lu-DOTATATE Radionuclide in Adults With Progressive or High-risk Meningioma

This single arm, open-label study will evaluate the efficacy of Lutathera (177Lu-DOTATATE) administered intravenously every 8 weeks for a total of 4 doses in patients with progressive WHO I-III

definitive radiation therapy
ebrt
measurable disease
platelet count
residual tumor
  • 40 views
  • 09 Feb, 2022
  • 1 location
Neoadjuvant PRRT With 177Lu-DOTATATE Followed by Surgery for Resectable PanNET

Peptide Receptor Radionuclide Therapy (PRRT) is based on specific somatostatin receptor targeting with radiolabelled analogues 90Y-DOTATOC and 177Lu-DOTATATE. These two most commonly used

ct scan
radionuclide therapy
pancreatic net
metastasis
cancer
  • 0 views
  • 05 Sep, 2021
  • 1 location
An Investigational Scan (68Ga-DOTATATE PET/CT) in Diagnosing Pediatric Metastatic Neuroendocrine Tumors

This trial studies how well an investigational scan called 68Ga-DOTATATE PET/CT works in diagnosing pediatric patients with neuroendocrine tumors that have spread to other places in the body

ganglioneuroblastoma
68ga-dotatoc
  • 0 views
  • 27 Jun, 2021
  • 1 location
Dual Tracer (68Ga-DOTATATE and 18F-FDG) PET Imaging in G2 & G3 Gastroenteropancreatic Neuroendocrine Tumors

The variable clinical outcome of patients with G2 & G3 well diff GEP-NETs makes the selection of an optimal treatment strategy challenging. Initial data suggests that high DOTATATE

  • 0 views
  • 04 May, 2021
  • 1 location
Use of Gallium-68 HA-DOTATATE PET/CT in Giant Cell Arteritis (GCA)

The aim of this study is to compare the use of FDG PET/CT to Ga-68 HA-DOTATATE (abbreviated DOTATATE) PET/CT in patients with active giant cell arteritis (GCA) started on prednisone to

magnetic resonance angiography
headache
artery biopsy
fdg pet/ct
polymyalgia
  • 0 views
  • 27 Apr, 2022
  • 1 location